{"id":56179,"date":"2026-11-09T16:55:09","date_gmt":"2026-11-09T15:55:09","guid":{"rendered":"https:\/\/drgonzalezcantero.com\/international-patients\/"},"modified":"2026-11-09T19:23:27","modified_gmt":"2026-11-09T18:23:27","slug":"international-patients","status":"publish","type":"page","link":"https:\/\/drgonzalezcantero.com\/en\/international-patients\/","title":{"rendered":"International patients"},"content":{"rendered":"
\n
\n
\n

Dr. \u00c1lvaro Gonz\u00e1lez Cantero, MD, PhD<\/p>\n<\/div><\/div>\n\n

Psoriasis care for international patients and expats<\/h1>\n<\/div><\/div>\n\n

In-person consultations and telemedicine<\/p>\n<\/div><\/div>\n\n

Grupo Pedro Ja\u00e9n | Madrid, Spain<\/p>\n<\/div><\/div>\n\n

Request an appointment<\/a><\/div>\n<\/div>\n\n
\n
\"Dr.<\/span><\/div>\n<\/div>\n<\/div>\n
<\/div><\/div>\n\n
\n
\n
\n

International dermatology care<\/p>\n

Clinical expertise, research and advanced treatments for patients worldwide<\/h2>\n<\/div><\/div>
<\/div><\/div>\n\n

When psoriasis remains difficult to control, follows a complex course or calls for challenging treatment decisions, some patients look beyond their home country for a more specialised assessment.<\/p>\n

Dr. \u00c1lvaro Gonz\u00e1lez Cantero sees international patients who would like a thorough review of their diagnosis, wish to explore further treatment options or are seeking a second opinion. His practice also welcomes expatriates living in Spain who need specialist dermatological care.<\/p>\n

His work brings together clinical practice, research, university teaching and regular contributions as a speaker at scientific conferences and expert meetings around the world.<\/p>\n

He leads the Psoriasis and Inflammatory Skin Diseases Unit at Grupo Pedro Ja\u00e9n, carries out clinical and research work at Ram\u00f3n y Cajal University Hospital, and contributes to research conducted at ICMR (International Center for Medical Research), a dermatology research centre of the Pedro Ja\u00e9n Foundation.<\/p>\n

He is also an Associate Professor in the Department of Medicine at Universidad Francisco de Vitoria. His background includes clinical observerships at Baylor University Medical Center in Dallas and the University of Pennsylvania, as well as ongoing exchanges with dermatologists and researchers internationally.<\/p>\n

His patients include people with mild or moderate psoriasis that remains inadequately controlled, alongside those with severe or particularly complex disease. In-person appointments and telemedicine can be combined, where appropriate, to make assessment and follow-up more practical for patients living abroad.<\/p>\n<\/div><\/div>\n<\/div>\n\n

\n
\"Grupo<\/span><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n
\n
\n
\n

Clinical experience, scientific rigour and individualised assessment guide care.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n

<\/div><\/div>
\n
\n
\n

A 360-degree approach<\/p>\n

Psoriasis: more than a skin condition<\/h2>\n<\/div><\/div>\n\n
<\/div><\/div>\n\n

A major focus of Dr. Gonz\u00e1lez Cantero's research has been the relationship between psoriasis, systemic inflammation and associated health conditions.<\/p>\n

Some people with psoriasis have an increased risk of conditions such as psoriatic arthritis, cardiovascular disease, fatty liver disease and metabolic disorders.<\/p>\n

This research underpins an integrated approach<\/a> that considers more than the visible skin lesions. It aims to identify relevant comorbidities and risk factors early, and to support prevention, further assessment and appropriate management whenever needed.<\/p>\n

This approach is relevant both to mild or moderate psoriasis that is difficult to manage and to more severe or complex cases in which advanced therapies may need to be considered.<\/p>\n

Treatment decisions are individualised, taking into account disease activity, previous therapies, associated conditions and each patient's circumstances.<\/p>\n<\/div><\/div>\n<\/div>\n\n

\n
\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\"Body\n\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Cardiovascular\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Cardiovascular risk assessment<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Fatty\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Fatty liver disease<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Emotional\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Emotional impact<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Phototherapy\"\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Phototherapy<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Biological\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Biological therapy<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Laser\"\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Laser<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Metabolic\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Metabolic syndrome<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"Psoriatic\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
Psoriatic arthritis<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t<\/div>\n\n\t
\n\t\t
\n\t\t\t